Literature DB >> 28783771

PURLs: Direct oral anticoagulants or warfarin for A fib?

Corey Lyon1, Alex Reed1, Shailendra Prasad2.   

Abstract

A recent study evaluated the effectiveness of 3 direct oral anticoagulants and warfarin in patients with atrial fibrillation. So which agents came out on top?

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28783771      PMCID： PMC5549658     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  8 in total

1.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  National Trends in Ambulatory Oral Anticoagulant Use.

Authors:  Geoffrey D Barnes; Eleanor Lucas; G Caleb Alexander; Zachary D Goldberger
Journal:  Am J Med       Date:  2015-07-02       Impact factor: 4.965

4.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

Review 5.  Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Authors:  Francesco Dentali; Nicoletta Riva; Mark Crowther; Alexander G G Turpie; Gregory Y H Lip; Walter Ageno
Journal:  Circulation       Date:  2012-10-15       Impact factor: 29.690

Review 6.  Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials.

Authors:  George Ntaios; Vasileios Papavasileiou; Hans-Christoph Diener; Konstantinos Makaritsis; Patrik Michel
Journal:  Stroke       Date:  2012-11-13       Impact factor: 7.914

Review 7.  Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.

Authors:  Soheir S Adam; Jennifer R McDuffie; Thomas L Ortel; John W Williams
Journal:  Ann Intern Med       Date:  2012-12-04       Impact factor: 25.391

8.  Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.

Authors:  Torben Bjerregaard Larsen; Flemming Skjøth; Peter Brønnum Nielsen; Jette Nordstrøm Kjældgaard; Gregory Y H Lip
Journal:  BMJ       Date:  2016-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.